Tara L. Dall MD FNLA

Preventive Medicine, Women's Health, Obesity Medicine & Nutrition

Physician/ Virtual Medicine/ Motivational speaker

601 Genesee StUnit 303Delafield, WI 53018
Phone+1 888-498-5296
Fax+1 888-495-8194

Dr. Dall is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dall's full profile Already have an account?

Summary

Board certified Lipidologist, national and international speaker on heart disease and diabetes prevention as well as role of biomarkers in clinical medicine. Greater than 15 years clinical experience using advanced biomarkers. Cofounder Lecturepad.org and FHITtv.org. Cofounder AvanceMD Concierge. www.avanceMD.com

Education & Training

University of Wisconsin (Madison)Residency, Family Medicine, 1998 - 2001
University of Wisconsin School of Medicine & Public HealthClass of 1998
University Wisconsin MadisonB.S., Zoology, 1991 - 1994

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

VA State Medical License 2012 - 2028
WI State Medical License 1999 - 2027
American Board of Family Medicine Family Medicine

Awards, Honors, & Recognition

Wall of Stars Science and Technology Waukesha North High School, 2013
15 Richmond Healthcare Leaders 40 & Under Our Health Magazine, 2012
Compassionate Doctor Recognition 2011

Publications & Presentations

PubMed

8 citations
Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population
Elliott Wolin, Justin White, James V. Pottala, Maciek Sasinowski, Tara Dall
Journal of Clinical Lipidology. 2015-11-01
17 citations
Discordance between apolipoprotein B and low-density lipoprotein particle number is associated with insulin resistance in clinical practice
Stephen A. Varvel, Thomas D. Dayspring, Yvette Edmonds, Dawn L. Thiselton, Leila Ghaedi
Journal of Clinical Lipidology. 2015-03-01
24 citations
Serum α-hydroxybutyrate (α-HB) predicts elevated 1 h glucose levels and early-phase β-cell dysfunction during OGTT
Stephen A. Varvel, James V. Pottala, Dawn L. Thiselton, Rebecca E. Caffrey, Tara Dall
BMJ Open Diabetes Research & Care. 2014-09-01

Journal Articles

Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population
Elliott Wolin, PhD, Justin White, MS, James V. Pottala, PhD, Maciek Sasinowski, PhD, MD, Tara Dall, MD, Thomas D. Dayspring, MD, Joseph P. McConnell, PhD, Daniel M. Ho..., Journal of Clinical Lipidology, 1/1/2015
Comprehensive Biomarker Testing of Glycemia, Insulin Resistance, and Beta Cell Function Has Greater Sensitivity to Detect Diabetes Risk Than Fasting Glucose and HbA1c ...
S Varvel, S Voros, D Thiselton, J Pottala, T Dall, G Warnick, J McConnell, L Ghaedi , M Sasinowski, T Graham, J Cardiovasc Transl Res, 1/1/2014
Discordance between apolipoprotein B and low-density lipoprotein particle number is associated with insulin resistance in clinical practice
Stephen A. Varvel, PhD, Thomas D. Dayspring, MD, Yvette Edmonds, PhD, Dawn L. Thiselton, PhD, Leila Ghaedi, PhD, Szilard Voros, MD, Joseph P. McConnell, PhD, Maciek Sa..., J Clin Lipidol, 1/1/2014

Abstracts/Posters

Discordance between apoB and LDL-P in clinical practice is associated with insulin resistance.
Stephen A. Varvel, PhD; Thomas D. Dayspring, MD; Tara Dall, MD; Dawn L. Thiselton, PhD; Yvette M. Edmonds, PhD; Joseph P. McConnell, PhD; G. Russell Warnick, MS, MBA, National Lipid Association Annual Scientific sessions, Las Vegas, NV, 1/31/2013
Determination of Desmosterol, Campesterol, Cholestanol and b-Sitosterol in plasma utilizing LC-MS/MS in Clinical Diagnostics
James Bruton, Joseph McConnell, Dan Hoefner, Tara Dall, Thomas Dayspring, American Society for Mass Spectrometry, 1/8/2013
Heterogeneity of Low-Density Lipoprotein Particle Number (LDL-P) at Normal Concentrations of Lipoprotein (a) in Hyperlipidemia Patients
Hector Malave, MD, Richard Wright, MD, Tara Dall, MD, Barney B. Beaver, DO, Ray Pourfarzib, PhD, National Lipid Association Annual Scientific sessions, Scottsdale, AZ, 1/31/2012

Lectures

Heart Disease and Stroke Prevention: Information that may save your life
George Washington University, Washington, DC - 1/19/2016
Early detection for heart disease and diabetes through the use of biomarker testing.
1/3/2016
Biomarkers role in personalized medicine.
Baton Rouge, LA - 1/27/2015

Other

Learn important information about high cholesterol and diabetes in children.
Dall TL, WTVR, Virginia This Morning
1/16/2015
Insulin resistance: Belly fat
Dall TL, WTVR, Virginia This Morning
1/1/2015
Managing statin Tolerance and Adherence
Dall TL, Heart.org
1/31/2012